If You Invested $10,000 in Moderna in 2019, This Is How Much You Would Have Today
(NASDAQ: MRNA) shares skyrocketed in the early stages of the pandemic as the biotech company became one of the first to bring a vaccine to market. That vaccine went on to generate billions of dollars in earnings for Moderna, allowing the company to invest in areas to speed up drug development -- such as artificial intelligence (AI) -- and advance its pipeline.
The stock hasn't been a top performer in recent times, though, declining about 80% from its peak back in 2021. Many investors, seeing that post-pandemic vaccine sales will be much lower than early pandemic sales, have turned their backs on the stock.
What about people who already bought the shares? Those who picked up Moderna as a short-term investment might have won big or lost out -- depending on when they sold the stock.
Source Fool.com
Moderna Inc. Stock
We see a rather positive sentiment for Moderna Inc. with 17 Buy predictions and 2 Sell predictions.
With a target price of 129 € there is a slightly positive potential of 15.61% for Moderna Inc. compared to the current price of 111.58 €.
